318 related articles for article (PubMed ID: 19168157)
1. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.
Adamus G
Autoimmun Rev; 2009 Mar; 8(5):410-4. PubMed ID: 19168157
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
3. Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies?
Adamus G
Front Immunol; 2018; 9():765. PubMed ID: 29713325
[TBL] [Abstract][Full Text] [Related]
4. Molecular biomarkers for autoimmune retinopathies: significance of anti-transducin-alpha autoantibodies.
Adamus G; Brown L; Weleber RG
Exp Mol Pathol; 2009 Dec; 87(3):195-203. PubMed ID: 19744478
[TBL] [Abstract][Full Text] [Related]
5. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
[TBL] [Abstract][Full Text] [Related]
6. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
7. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
8. [Ocular paraneoplastic syndrome: cancer-associated retinopathy].
Sampedro A; Carballo C; Barbón JJ; Andrés A; Viña C; Abelairas V
Arch Soc Esp Oftalmol; 2013 Oct; 88(10):407-9. PubMed ID: 24060306
[TBL] [Abstract][Full Text] [Related]
9. Cone dysfunction as a paraneoplastic syndrome associated with retinal antigens approximating 40 kiloDalton.
Parc CE; Azan E; Bonnel S; Sahel JA; Kaplan J; Thirkill CE
Ophthalmic Genet; 2006 Jun; 27(2):57-61. PubMed ID: 16754207
[TBL] [Abstract][Full Text] [Related]
10. Unique epitopes for carbonic anhydrase II autoantibodies related to autoimmune retinopathy and cancer-associated retinopathy.
Adamus G; Yang S; Weleber RG
Exp Eye Res; 2016 Jun; 147():161-168. PubMed ID: 27185162
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
Adamus G
Autoimmun Rev; 2003 Mar; 2(2):63-8. PubMed ID: 12848960
[TBL] [Abstract][Full Text] [Related]
12. [Severe visual loss caused by autoimmune retinopathy].
ten Berge JC; Schreurs MW; Dufour-van den Goorbergh BC; de Witte PM; van Schooneveld MJ; Rothova A
Ned Tijdschr Geneeskd; 2015; 159():A8039. PubMed ID: 25654680
[TBL] [Abstract][Full Text] [Related]
13. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.
Khan N; Huang JJ; Foster CS
Semin Ophthalmol; 2006; 21(3):135-41. PubMed ID: 16912011
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated retinopathy vs recoverin-associated retinopathy.
Keltner JL; Thirkill CE
Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
[No Abstract] [Full Text] [Related]
15. Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy.
Peek R; Dijkstra BG; Meek B; Kuijpers RW
Clin Exp Immunol; 2002 Jun; 128(3):498-503. PubMed ID: 12067305
[TBL] [Abstract][Full Text] [Related]
16. Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells.
Adamus G; Amundson D; Seigel GM; Machnicki M
J Autoimmun; 1998 Dec; 11(6):671-7. PubMed ID: 9878089
[TBL] [Abstract][Full Text] [Related]
17. Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction.
Kondo M; Sanuki R; Ueno S; Nishizawa Y; Hashimoto N; Ohguro H; Yamamoto S; Machida S; Terasaki H; Adamus G; Furukawa T
PLoS One; 2011; 6(5):e19911. PubMed ID: 21611200
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature.
Aronow ME; Adamus G; Abu-Asab M; Wang Y; Chan CC; Zakov ZN; Singh AD
Surv Ophthalmol; 2012 Nov; 57(6):558-64. PubMed ID: 22784677
[TBL] [Abstract][Full Text] [Related]
19. Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.
Adamus G
Invest Ophthalmol Vis Sci; 2015 Mar; 56(3):1680-8. PubMed ID: 25754855
[TBL] [Abstract][Full Text] [Related]
20. The cancer-associated retinopathy antigen is a recoverin-like protein.
Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
